The TGA is testing a range of ARB medications for contamination following the recall of two valsartan brands last year.

Mylan and Apotex withdrew their valsartan products after regulators found they

GPs will be able to access a specific Medicare item to assess their patients’ risk of heart disease, despite an MBS Review Taskforce committee rejecting the idea in December.

The Federal Government

Poor rates of referral to cardiac rehabilitation are among the barriers to improving secondary prevention of cardiovascular disease, a report says.

The report, No Second Chances, from the Baker Heart

Tackling sexism is on the agenda of the peak professional body for cardiologists, which has set up a working group to address issues around training and promotion of women.

The Cardiac Society of

Comorbidities such as smoking, anxiety and depression account for the increased risk of cardiovascular disease (CVD) in veterans with post-traumatic stress disorder (PTSD), according to an analysis of

Poor rates of referral to cardiac rehabilitation are among the barriers to improving secondary prevention of cardiovascular disease, a report says.

The report, No Second Chances, from the Baker Heart

A leading cardiovascular expert has called for a shift in focus towards secondary prevention of cardiovascular disease, saying more can be done for those who have already experienced an event.

Not

Familial hypercholesterolaemia (FH) is the most common form of inherited hyperlipidaemia, resulting in accelerated onset of atherosclerotic cardiovascular disease.1

People with FH suffer coronary

The number of push-ups a man can do in a GP's room may be a good predictor of his risk of developing heart disease, new research suggests.

In a study of more than 1100 male firefighters followed for

Biologic therapy in patients with severe psoriasis is associated with significant improvements in coronary-artery plaque characteristics, according to new research.

Lead author Dr Nehal Mehta from